Back
Galera Therapeutics 10K Form
Sell
17
GRTX
Galera Therapeutics
Last Price:
0.03
Seasonality Move:
31.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GRTX News And Ratings
See the #1 stock for the next 7 days that we like better than GRTX
GRTX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-2.72M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.54 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.51000 |
|---|---|
| Net Income (TTM): | $-29.11M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Galera Therapeutics Earnings Forecast
Key Galera Therapeutics Financial Ratios
- The Interest Expense is -19.32% of Operating Income.
- Per Share Earnings over the last 7 years have been positive in 4 years.
Galera Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GRTX |
| CUSIP: | 36338D |
| Website: | galeratx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GRTX Technical Analysis vs Fundamental Analysis
Sell
17
Galera Therapeutics (GRTX)
is a Sell
Is Galera Therapeutics a Buy or a Sell?
-
Galera Therapeutics stock is rated a Sell
The current Galera Therapeutics [GRTX] share price is $0.03. The Score for GRTX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.